Скачать или смотреть Covaxin Phase 3 Data Shows 77.8% Efficacy, Says Lancet

Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against symptomatic COVID-19 in a long-awaited analysis published in The Lancet. The study also found it to be 65.2 per cent effective against the more dangerous Delta variant of the coronavirus in its preliminary analysis but said further investigations are necessary to confirm it.

About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe to our channels:
NDTV: https://www.youtube.com/user/ndtv?sub...
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindi...

Follow us on Social Media:
Like us on Facebook:   / ndtv  
Follow us on Twitter:   / ndtv  
Follow us on Koo: https://www.kooapp.com/profile/ndtv
Follow us on Instagram:   / ndtv  
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi

Follow us on Google News for Breaking and Latest News Updates:
NDTV: https://bit.ly/3e5ngbP
NDTV India (Hindi News): https://bit.ly/3mNVwMY

Download NDTV Mobile Apps:
http://www.ndtv.com/page/apps

Watch More Videos:
http://www.ndtv.com/video?yt

#BreakingNews #LatestNews #TodayNews #PoliticalNews #News